feed,title,long_url,short_url
🔐MarketWatch,Travere Therapeutics stock slides 35% after announcing disappointing results from 2-year trial of kidney drug,http://www.marketwatch.com/news/story/travere-therapeutics-stock-slides-35/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D71E8%2D0690A6023B6D%7D&siteid=rss,https://da.gd/HcuMN
